x

Posted 31 March, 2023

AMARIN CORP PLC\UK appointed new CEO

CEO Change detected for ticker Nasdaq:AMRN in a 8-K filed on 31 March, 2023.


  On March 27, 2023, Karim Mikhail notified Amarin Corporation plc (the "Company") of his decision to resign as President and Chief Executive Officer of the Company, effective immediately.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of AMARIN CORP PLC\UK
Health Care/Life Sciences • Biotechnology
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Market Cap
$378M
View Company Details
AMARIN CORP PLC\UK by TradingView
Relevant filing section
Item 5.02(b) 
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers 


On March 27, 2023, Karim Mikhail notified Amarin Corporation plc (the "Company") of his decision to resign as President and Chief Executive Officer of the Company, effective immediately. Mr. Mikhail has asserted that he is entitled to severance payments as the result of his resignation, which the Company disagrees with and intends to dispute. The Company is in the process of identifying a permanent replacement for Mr. Mikhail.